• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding

Factor XIII Deficiency

This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Diagnosis

Routine laboratory tests cannot be used to confirm factor XIII deficiency because none of them test clot stability.18 Specific investigations are needed, divided into screening tests, functional assays and immunological assays.

Screening tests
The most common screening test assesses clot stability. If the sample clot breaks down within a few hours, the patient likely is suffering from severe factor XIII deficiency, provided that fibrinogen levels are normal. If factor XIII is present in the sample, the clot remains stable after 24 hours.18 Notably, only very low levels of factor XIII are required for the clot to stabilize – a fibrin meshwork is possible when factor XIII is present at 1–3% of normal levels.19 Factor XIII deficiency is confirmed using an assay capable of measuring factor XIII levels.

Functional assays
Two commercially available assays measure factor XIII levels indirectly by monitoring the level of specific chemicals (ammonia or synthetic amine) involved in the cross-linking process responsible for factor XIII-mediated clot stability:18-19

Immunological assays
The presence of factor XIII in plasma can also be measured directly using an enzyme-linked immunosorbent assay (ELISA).19



Last Updated: 6/19/2013 5:45 PM
  • E-mail
  • Print
  • Share